article · Toxicology and Industrial Health
Aluminium phosphide (AlP) is a well-known toxic pesticide, but its dose-dependent toxicity and the distinction between safe and harmful exposure levels remain poorly established. Thus, the present study aimed to investigate the dose-dependent toxicity of AlP on biochemical biomarkers, antioxidant defense responses, and histological changes in rat liver and kidneys. Adult male Wistar rats were treated orally with increasing AlP doses (0.38, 0.58, and 1.15 mg/kg body weight, corresponding to LD 50 /30, LD 50 /20, and LD 50 /10, respectively) for 4 weeks. Results revealed a marked increase in body weight, serum levels of AST (aspartate aminotransferase), ALT (alanine aminotransferase), and PAL (alkaline phosphatase), and levels of urea, creatinine, and malondialdehyde (MDA) of treated rats as compared with controls. However, glutathione content and enzymatic activity of catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), and glutathione S-transferase (GST) in liver and kidney tissue were significantly decreased compared with controls. These biochemical changes following AlP treatment also mirrored hepatic and renal histopathological observations, showing dose-dependent tissue alterations, with a more pronounced effect in the higher AlP dose-treated rats. Conclusively, sub-acute AlP exposure caused dose-dependent liver and kidney toxicity, high doses induced pronounced damage, and low doses showed mild or minimal effects.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1177/07482337261467527
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.